Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression

Cellular and Molecular Neurobiology

Volumn 26, Issue 4-6, 2006, Pages 659-678

  Weihe, Eberhard ^a   Depboylu, Candan ^a   Schuẗz, Burkhard ^a   Schäfer, Martin K H ^a   Eiden, Lee E ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Aromatic amino acid decarboxylase dopa decarboxylase; CNS neuronal phenotypes; Dopaergic; Dopaminergic; Tyrosine hydroxylase; Vesicular monoamine transporter

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; LEVODOPA; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL; ARTICLE; BRAIN; FEMALE; MACACA; MALE; METABOLISM; MOUSE; NERVE CELL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; DOPA DECARBOXYLASE; FEMALE; LEVODOPA; MACACA MULATTA; MALE; MICE; NEURONS; RATS; TISSUE DISTRIBUTION; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 33846022027     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-006-9053-9     Document Type: Article

References (54)

1. Andresen, M. C., Doyle, M. W., Jin, Y.H., and Bailey, T. W. (2001). Cellularmechanisms of baroreceptor integration at the nucleus tractus solitarius. Ann. N.Y. Acad. Sci. 940:132-141. (Pubitemid 32623389)
2. Anlauf, M., Schäfer, M. K.-H., Eiden, L. E., and Weihe, E. (2003). Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic and catecholaminergic phenotypes. J. Comp. Neurol. 459:90-111. (Pubitemid 36348866)
3. Asmus, S. E., Parsons, S., and Landis, S. C. (2000). Developmental changes in the transmitter properties of sympathetic neurons that innervate the periosteum. J. Neurosci. 20:1495-1504. (Pubitemid 30220428)
4. Axelrod, J. (1986). Doing research in the Intramural Program of the National Institutes of Health. Perspect. Biol. Med. 29:S131-S137.
5. Balan, I. S., Ugrumov, M. V., Calas, A., Mailly, P., Kreiger, M., and Thibault, J. (2000). Tyrosine hydroxylase-expressing and/or aromatic L-amino acid decarboxylase-expressing neurons in the mediobasal hypothalamus of perinatal rats: differentiation and sexual dimorphism. J. Comp. Neurol. 425:167-176. (Pubitemid 30660444)
6. Betarbet, R., Turner, R., Chockkan, V., DeLong, M. R., Allers, K. A., Walters, J., Levey, A. I., and Greenamyre, J. T. (1997). Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17:6761-6768.
7. Carlsson, A. (2001). A paradigm shift in brain research. Science 294:1021-1024.
8. Cases, O., Lebrand, C., Giros, B., Vitalis, T., De Maeyer, E., Caron, M. G., Price, D. J., Gaspar, P., and Seif, I. (1998). Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase. A knock-outs. J. Neurosci. 18:6914-6927. (Pubitemid 28388021)
9. Cochard, P., Goldstein, M., and Black, I. B. (1978). Ontogenetic appearance and disappearance of tyrosine hydroxylase and catecholamines in the rat embryo. Proc. Natl. Acad. Sci. U.S.A. 75:2986-2990. (Pubitemid 8378750)
10. Del Tredici, K., Rub, U., De Vos, R. A., Bohl, J. R., and Braak, H. (2002).Where does parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61:413-426. (Pubitemid 34533671)
11. Erickson, J. D., Schäfer, M. K.-H., Bonner, T. I., Eiden, L. E., and Weihe, E. (1996). Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. U.S.A. 93:5166-5171. (Pubitemid 26162890)
12. Ershov, P. V., Ugrumov, M. V., Calas, A., Krieger, M., and Thibault, J. (2002a). Differentiation of tyrosine hydroxylase-synthesizing and/or aromatic L-amino acid decarboxylase-synthesizing neurons in the rat mediobasal hypothalamus: Quantitative double-immunofluorescence study. J. Comp. Neurol. 446:114-22. (Pubitemid 34252838)
13. Ershov, P. V., Ugrumov, M. V., Calas, A., Krieger, M., and Thibault, J. (2005). Degeneration of dopaminergic neurons triggers an expression of individual enzymes of dopamine synthesis in nondopaminergic neurons of the arcuate nucleus in adult rats. J. Chem. Neuroanat. 30:27-33. (Pubitemid 40943566)
14. Ershov, P. V., Ugrumov, M. V., Calas, A., Makarenko, I. G., Krieger, M., and Thibault, J. (2002b). Neurons possessing enzymes of dopamine synthesis in the mediobasal hypothalamus of rats. Topographic relations and axonal projections to the median eminence in ontogenesis. J. Chem. Neuroanat. 24:95-107. (Pubitemid 35007326)
15. Fon, E. A., Pothos, E. N., Sun, B.-C., Killeen, N., Sulzer, D., and Edwards, R. H. (1997). Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271-1283. (Pubitemid 28030546)
16. Gaspar, P., Berger, B., Febvret, A., Vigny, A., Krieger-Poulet, M., and Borri-Volta Horni, C. (1987). Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catechol aminergic group? Neurosci. Lett. 80:257-262. (Pubitemid 17140125)
17. Guillemot, F., Lo, L.-C., Hohnson, J. E., Auerbach, A., Anderson, D. J., and Joyner, A. L. (1993). Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 75:463-476. (Pubitemid 23335072)
18. Habecker, B. A., Klein, M. G., Sundgren, N. C., Li, W., and Woodward, W. R. (2002). Developmental regulation of neurotransmitter phenotype through tetrahydrobiopterin. J. Neurosci. 22:9445-9452. (Pubitemid 35356187)
19. Halasz, N., Ljungdahl, A., Hokfelt, T., Johansson, O., Goldstein, M., Park, D., and Biberfeld, P. (1977). Transmitter histochemistry of the rat olfactory bulb. I. Immunohistochemical localization of monoamine synthesizing enzymes. Support for intrabulbar, periglomerular dopamine neurons. Brain Res. 126:455-474. (Pubitemid 8090745)
20. Hansson, S., Mezey, E., and Hoffman, B. J. (1998a). Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat. Dev. Brain Res. 110:159-174. (Pubitemid 28442627)
21. Hansson, S. R., Hoffman, B. J., and Mezey, E. (1998b). Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system. Dev. Brain Res. 110:135-158. (Pubitemid 28442626)
22. Hirayama, K., and Kapatos, G. (1998). Nigrostriatal dopamine neurons express low levels of GTP cyclohydrolase I protein. J. Neurochem. 70:164-170. (Pubitemid 28020840)
23. Hirsch, M.-R., Tiveron, M.-C., Guillemot, F., Brunet, J.-F., and Goridis, C. (1998). Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 125:599-608. (Pubitemid 28108085)
24. Hoffman, B. J., Palkovits, M., Pacak, K., Hansson, S. R., and Mezey, E. (1998). Regulation of dopamine transporter mRNA levels in the central nervous system. Adv. Pharmacol. 42:202-206.
25. Huang, M. H., Bahl, J. J., Wu, Y., Hu, F., Larson, D. F., Roeske, W. R., and Ewy, G. A. (2005). Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. Am. J. Physiol. Heart Circ. Physiol. 288:H497-H503. (Pubitemid 40139630)
26. Ikemoto, K., Nagatsu, I., Kitahama, K., Jouvet, A., Nishimura, A., Nishi, K., Maeda, T., and Arai, R. (1998a). A dopamine-synthesizing cell group demonstrated in the human basal forebrain by dual labeling immunohistochemical technique of tyrosine hydroxlase and aromatic L-amino acid decarboxylase. Neurosci. Lett. 243:129-132. (Pubitemid 28109428)
27. Ikemoto, K., Nagatsu, I., Nishimura, A., Nishi, K., and Arai, R. (1998b). Do all of human midbrain tyrosine hydroxylase neurons synthesize dopamine? Brain Res. 805:255-258. (Pubitemid 29005141)
28. Jonakait, G. M., Markey, K. A., Goldstein, M., Dreyfus, C. F., and Black, I. B. (1985). Selective expression of high-affinity uptake of catecholamines by transiently catecholaminergic cells of the rat embryo: studies in vivo and in vitro. Dev. Biol. 108:6-17. (Pubitemid 15143496)
29. Kariya, S., Takahaski, N., Hirano., M., and Ueno, S. (2005). Increased vulnerability to L-Dopa toxicity in dopaminergic neurons from VMAT2 heterozygote Knockout mice. J. Mol. Neurosci. 27:277-279. (Pubitemid 41572674)
30. Kitahama, K., Ikemoto, K., Jouvet, A., Nagatsu, I., Geffard, M., Okamura, H., and Pearson, J. (1998). Dopamine synthesizing enzymes in paraventricular hypothalamic neurons of the human andmonkey (Macaca fuscata). Neurosci. Lett. 243:1-4. (Pubitemid 28109396)
31. Kitahama, K., Sakamoto, N., Jouvet, A., Nagatsu, I., and Pearson, J. (1996). Dopamine-beta-hydroxylase and tyrosine hydroxylase immunoreactive neurons in the human brainstem. J. Chem. Neuroanat. 10:137-146. (Pubitemid 26177665)
32. Komori, K., Fujii, T., and Nagatsu, I. (1991). Do some tyrosine hydroxylase-immunoreactive neurons in the human ventrolateral arcuate nucleus and globus pallidus produce only L-dopa? Neurosci. Lett. 133:203-206.
33. Landis, S. C., Jackson, P. C., Fredieu, J. R., and Thibault, J. (1987). Catecholaminergic properties of cholinergic neurons and synapses in adult rat ciliary ganglion. J. Neurosci. 7:3574-3587. (Pubitemid 18000685)
34. Landis, S. C., Siegel, R. E., and Schwab, M. (1988). Evidence for neurotransmitter plasticity in vivo. II. Immunocytochemical studies of rat sweat gland innervation during development. Dev. Biol. 126:129-140. (Pubitemid 18077592)
35. Lebrand, C., Cases, O., Adelbrecht, C., Doye, A., Alvarez, C., El Mestikawy, S., Seif, I., and Gaspar, P. (1996). Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17:823-835. (Pubitemid 26424011)
36. Lebrand, C., Cases, O., Wehrlé, R., Blakely, R. D., Edwards, R. H., and Gaspar, P. (1998). Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 401:506-524. (Pubitemid 28509882)
37. Liang, N. Y., and Rutledge, C. O. (1982). Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31:2479-2484. (Pubitemid 12095306)
38. Mack, G. W., Shannon, L. M., and Nadel, E. R. (1986). Influence of beta-adrenergic blockade on the control of sweating in humans. J. Appl. Physiol. 61:1701-1705. (Pubitemid 17196222)
39. Misu, Y., Goshima, Y., and Miyamae, T. (2002). Is DOPA a neurotransmitter? Trends Pharmacol. Sci. 23:262-268. (Pubitemid 34655731)
40. Misu, Y., Kitahama, K., and Goshima, Y. (2003). L -3,4- Dihydroxyphenylalanine as a neurotransmitter candidate in the central nervous system. Pharmacol. Ther. 97:117-137. (Pubitemid 36138819)
41. Palfi, S., Leventhal, L., Chu, Y., Ma, S. Y., Emborg, M., Bakay, R., Deglon, N., Hantraye, P., Aebischer, P., and Kordower, J. H. (2002). Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primatemodels of nigrostriatal degeneration. J. Neurosci. 22:4942-4954. (Pubitemid 37465609)
42. Rao, M. S., Jaszczak, E., and Landis, S. C. (1994). Innervation of footpads of normal and mutant mice lacking sweat glands. J. Comp. Neurol. 346:613-625. (Pubitemid 24258524)
43. Saavedra, J. M., Brownstein, M., Palkovits, M., Kizer, S., and Axelrod, J. (1974). Tyrosine hydroxylase and dopamine-beta-hydroxylase: distribution in the individual rat hypothalamic nuclei. J. Neurochem. 23:869-871.
44. Sanchez-Gonzalez, M. A., Garcia-Cabezas, M. A., Rico, B., and Cavada, C. (2005). The primate thalamus is a key target for brain dopamine. J. Neurosci. 25:6076-6083. (Pubitemid 40923474)
45. Saper, C. B., and Sawchenko, P. E. (2003). Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J. Comp. Neurol. 465:161-163. (Pubitemid 37100126)
46. Schütz, B., Schäfer, M. K.-H., Eiden, L. E., and Weihe, E. (1998a). Ontogeny of vesicular amine transporter expression in the rat: new perspectives on aminergic neuronal and neuroendocrine differentiation. Adv. Pharmacol. 42:903-908.
47. Schütz, B., Schäfer, M. K.-H., Eiden, L. E., and Weihe, E. (1998b). Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut. Dev. Brain Res. 106:181-204. (Pubitemid 28168484)
48. Ugrumov, M., Melnikova, V., Ershov, P., Balan, I., and Calas, A. (2002). Tyrosine hydroxylase- and/or aromatic L-amino acid decarboxylase-expressing neurons in the rat arcuate nucleus: ontogenesis and functional significance. Psychoneuroendocrinology 27:533-548. (Pubitemid 34310616)
49. Ugrumov, M. V. (1997). Hypothalamic monoaminergic systems in ontogenesis: Development and functional significance. Int. J. Dev. Biol. 41:809-816.
50. Ugrumov, M. V., Melnikova, V. I., Lavrentyeva, A. V., Kudrin, V. S., and Rayevsky, K. S. (2004). Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats. Neuroscience 124:629-635. (Pubitemid 38251329)
51. Weihe, E., Anlauf, M., Schäfer, M.-K. H., Hartschuh, W., and Eiden, L. E. (1998). VMAT2 is the transporter mediating sequestration of monoamines in rat and human platelets, mast cells, and cutaneous dendritic cells. (abstract). Soc. Neurosci. Abstr. Nov. 7-12: No. 301.1.
52. Weihe, E., and Eiden, L. E. (2000). Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 14:2435-2449.
53. Weihe, E., Schäfer, M. K.-H., Erickson, J. D., and Eiden, L. E. (1994). Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5:149-164.
54. Weihe, E., Schutz, B., Hartschuh, W., Anlauf, M., Schafer,M. K., and Eiden, L. E. (2005). Co-expression of cholinergic and noradrenergic phenotypes in human and non-human autonomic nervous system. J. Comp. Neurol. 492:370-379. (Pubitemid 41547322)